Larvol Delta - Tris-Pharma-Announces-Acquisition-of-Park-Therapeutics--Pain-Company-with-FirstInClass-Phase-IIIReady-New-Chemical-Entity-NCE

cebranopadol (GRT6005) - Assertio, Grunenthal

https://www.prnewswire.com/news-releases/tris-pharma-announces-acquisition-of-park-therapeutics--pain-company-with-first-in-class-phase-iii-ready-new-chemical-entity-nce-301280025.html

Apr 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next